Showing results (141-150 of 254) with videos related to
Sort By:
Pageof 26
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2025
Radiotherapy dose-response of mycosis fungoides with large cell transformationMartin J Higgins, Philippa Johnstone, H Miles Prince, et al.Hematological Oncology|June 16, 2006
The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilizationColm Keane, Simon Gibbs, John F Seymour, et al.British Journal of Haematology|August 4, 2004
Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cellsH Miles Prince, Paul J Simmons, Genevieve Whitty, et al.British Journal of Haematology|November 28, 2008
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access programJoseph R Mikhael, Andrew R Belch, H Miles Prince, et al.Current Rheumatology Reports|September 3, 2018
A Practical Approach to the Use of Conventional Synthetic, Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for the Treatment of Inflammatory Arthritis in Patients with a History of MalignancyPeter K K Wong, Hanish Bagga, Claire Barrett, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 6, 2016
Caregivers' information needs and their 'experiences of care' during treatment are associated with elevated anxiety and depression: a cross-sectional study of the caregivers of renal cancer survivorsDevesh V Oberoi, Vicki White, Michael Jefford, et al.British Journal of Haematology|August 22, 2009
Mantle cell lymphoma with central nervous system involvement: frequency and clinical featuresSaar Gill, Kirsten E Herbert, H Miles Prince, et al.Haematologica|July 21, 2007
Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcomeLinda Mileshkin, Dirk Honemann, Peter Gambell, et al.Eye (London, England)|February 3, 2009
Topical prostaglandin analogues do not affect selective laser trabeculoplasty outcomesD Singh, M A Coote, F O'Hare, et al.Blood|August 31, 2019
Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndromeCrystal Gao, Christopher McCormack, Carrie van der Weyden, et al.Pageof 26